These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

406 related articles for article (PubMed ID: 12365022)

  • 21. Autonomous growth of a human neuroblastoma cell line is mediated by insulin-like growth factor II.
    El-Badry OM; Romanus JA; Helman LJ; Cooper MJ; Rechler MM; Israel MA
    J Clin Invest; 1989 Sep; 84(3):829-39. PubMed ID: 2547840
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of growth and metastases of MDA-MB-435 human estrogen-independent breast cancers by an antagonist of growth hormone-releasing hormone.
    Chatzistamou I; Schally AV; Varga JL; Groot K; Busto R; Armatis P; Halmos G
    Anticancer Drugs; 2001 Oct; 12(9):761-8. PubMed ID: 11593058
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vitamin D and growth hormone regulate growth hormone/insulin-like growth factor (GH-IGF) axis gene expression in human fetal epiphyseal chondrocytes.
    Fernández-Cancio M; Audi L; Carrascosa A; Toran N; Andaluz P; Esteban C; Granada ML
    Growth Horm IGF Res; 2009 Jun; 19(3):232-7. PubMed ID: 19056306
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of IGF-I/IGF-IR circuit on the angiogenetic properties of Ewing's sarcoma cells.
    Strammiello R; Benini S; Manara MC; Perdichizzi S; Serra M; Spisni E; Picci P; Scotlandi K
    Horm Metab Res; 2003; 35(11-12):675-84. PubMed ID: 14710346
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antagonists of growth hormone-releasing hormone inhibit the growth of U-87MG human glioblastoma in nude mice.
    Kiaris H; Schally AV; Varga JL
    Neoplasia; 2000; 2(3):242-50. PubMed ID: 10935510
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of chronic cysteamine treatment on growth enhancement and insulin-like growth factor I and II mRNA levels in common carp tissues.
    Tse MC; Cheng CH; Chan KM
    Br J Nutr; 2006 Oct; 96(4):650-9. PubMed ID: 17010223
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cholecystokinin down-regulation by RNA interference impairs Ewing tumor growth.
    Carrillo J; García-Aragoncillo E; Azorín D; Agra N; Sastre A; González-Mediero I; García-Miguel P; Pestaña A; Gallego S; Segura D; Alonso J
    Clin Cancer Res; 2007 Apr; 13(8):2429-40. PubMed ID: 17438102
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of PC-3 human prostate cancers by analogs of growth hormone-releasing hormone (GH-RH) endowed with vasoactive intestinal peptide (VIP) antagonistic activity.
    Plonowski A; Varga JL; Schally AV; Krupa M; Groot K; Halmos G
    Int J Cancer; 2002 Apr; 98(4):624-9. PubMed ID: 11920625
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human osteosarcoma cell lines are dependent on insulin-like growth factor I for in vitro growth.
    Kappel CC; Velez-Yanguas MC; Hirschfeld S; Helman LJ
    Cancer Res; 1994 May; 54(10):2803-7. PubMed ID: 8168113
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of granulocyte-colony-stimulating factor and its receptor in human Ewing sarcoma cells and patient tumor specimens: potential consequences of granulocyte-colony-stimulating factor administration.
    Morales-Arias J; Meyers PA; Bolontrade MF; Rodriguez N; Zhou Z; Reddy K; Chou AJ; Koshkina NV; Kleinerman ES
    Cancer; 2007 Oct; 110(7):1568-77. PubMed ID: 17694551
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Potentiation of the inhibitory effect of growth hormone-releasing hormone antagonists on PC-3 human prostate cancer by bombesin antagonists indicative of interference with both IGF and EGF pathways.
    Plonowski A; Schally AV; Varga JL; Rekasi Z; Hebert F; Halmos G; Groot K
    Prostate; 2000 Jul; 44(2):172-80. PubMed ID: 10881027
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Overexpression of the insulin-like growth factor-1 receptor and autocrine stimulation in human cervical cancer cells.
    Steller MA; Delgado CH; Bartels CJ; Woodworth CD; Zou Z
    Cancer Res; 1996 Apr; 56(8):1761-5. PubMed ID: 8620490
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of ganitumab (AMG 479), alone and in combination with rapamycin, in Ewing's and osteogenic sarcoma models.
    Beltran PJ; Chung YA; Moody G; Mitchell P; Cajulis E; Vonderfecht S; Kendall R; Radinsky R; Calzone FJ
    J Pharmacol Exp Ther; 2011 Jun; 337(3):644-54. PubMed ID: 21385891
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antagonists of growth hormone-releasing hormone (GH-RH) inhibit in vivo proliferation of experimental pancreatic cancers and decrease IGF-II levels in tumours.
    Szepeshazi K; Schally AV; Groot K; Armatis P; Hebert F; Halmos G
    Eur J Cancer; 2000 Jan; 36(1):128-36. PubMed ID: 10741306
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Growth hormone-releasing hormone antagonist MZ-5-156 inhibits growth of DU-145 human androgen-independent prostate carcinoma in nude mice and suppresses the levels and mRNA expression of insulin-like growth factor II in tumors.
    Lamharzi N; Schally AV; Koppán M; Groot K
    Proc Natl Acad Sci U S A; 1998 Jul; 95(15):8864-8. PubMed ID: 9671770
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Normal human osteoblast-like cells consistently express genes for insulin-like growth factors I and II but transformed human osteoblast cell lines do not.
    Okazaki R; Conover CA; Harris SA; Spelsberg TC; Riggs BL
    J Bone Miner Res; 1995 May; 10(5):788-95. PubMed ID: 7639114
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Somatostatin inhibits basal and growth hormone-stimulated hepatic insulin-like growth factor-I production.
    Very NM; Kittilson JD; Klein SE; Sheridan MA
    Mol Cell Endocrinol; 2008 Jan; 281(1-2):19-26. PubMed ID: 18006145
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of proliferation of small intestinal and bronchopulmonary neuroendocrine cell lines by using peptide analogs targeting receptors.
    Kidd M; Schally AV; Pfragner R; Malfertheiner MV; Modlin IM
    Cancer; 2008 Mar; 112(6):1404-14. PubMed ID: 18224665
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of human growth hormone on human pancreatic carcinoma growth, protein, and cell cycle kinetics.
    Harrison LE; Blumberg D; Berman R; Ng B; Hochwald S; Brennan MF; Burt M
    J Surg Res; 1996 Mar; 61(2):317-22. PubMed ID: 8656602
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of insulin-like growth factors (IGF), FSH, and leptin on IGF-binding-protein mRNA expression in bovine granulosa and theca cells: quantitative detection by real-time PCR.
    Voge JL; Aad PY; Santiago CA; Goad DW; Malayer JR; Allen D; Spicer LJ
    Peptides; 2004 Dec; 25(12):2195-203. PubMed ID: 15572210
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.